Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Helen Ma · SciRah

Researcher profile · Semantic Scholar

Helen Ma

Share profile

Helen Ma — researcher profile on SciRah

h-index: 20
Works: 80
Citations: 3,109

Most-cited papers

An inhibitor of oxidative phosphorylation exploits cancer vulnerability
Jennifer R. Molina, Yu-Ting Sun, M. Protopopova, S. Gera +62 more
2018Nature Medicine842 citations Open access
Semantic Scholar
Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML.
C. Dinardo, I. Tiong, Anna Quaglieri, Sarah Macraild +25 more
2020Blood633 citations Open access
Semantic Scholar
Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia
Qi Zhang, B. Riley-Gillis, Li-Na Han, Yan-Nan Jia +37 more
2022Signal Transduction and Targeted Therapy187 citations Open access
Semantic Scholar
Combined Oral 5-Azacytidine and Romidepsin are Highly Effective in Patients with PTCL: A Multicenter Phase 2 Study.
L. Falchi, Helen Ma, S. Klein, J. Lue +17 more
2020Blood178 citations
Semantic Scholar
Inhibiting glutaminase in acute myeloid leukemia: metabolic dependency of selected AML subtypes
Polina R Matre, Juliana Vélez, R. Jacamo, Yuan Qi +21 more
2016OncoTarget161 citations Open access
Semantic Scholar
MLL-Rearranged Acute Lymphoblastic Leukemias Activate BCL-2 through H3K79 Methylation and Are Sensitive to the BCL-2-Specific Antagonist ABT-199
J. Benito, Laura J. Godfrey, K. Kojima, L. Hogdal +32 more
2015Cell Reports151 citations Open access
Semantic Scholar
Exogenous mitochondrial transfer and endogenous mitochondrial fission facilitate AML resistance to OxPhos inhibition
Kaori Saito, Qi Zhang, Haeun Yang, Kotoko Yamatani +19 more
2021Blood Advances82 citations Open access
Semantic Scholar
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia
J. Kerry, Laura J. Godfrey, E. Repapi, M. Tapia +12 more
2017Cell Reports82 citations Open access
Semantic Scholar
Hypoxia-activated prodrug TH-302 targets hypoxic bone marrow niches in pre-clinical leukemia models
J. Benito, M. Ramirez, N. Millward, Juliana Vélez +20 more
2015Clinical Cancer Research70 citations Open access
Semantic Scholar
Co-targeting BCL-XL and BCL-2 by PROTAC 753B eliminates leukemia cells and enhances efficacy of chemotherapy by targeting senescent cells
Yan-Nan Jia, Li-Na Han, Cassandra L. Ramage, Zhe Wang +16 more
2023Haematologica66 citations Open access
Semantic Scholar
Inhibition of mitochondrial complex I reverses NOTCH1-driven metabolic reprogramming in T-cell acute lymphoblastic leukemia
Natalia Baran, A. Lodi, Yogesh Dhungana, Shelley M. Herbrich +51 more
2022Nature Communications60 citations Open access
Semantic Scholar
Oral MEK 1/2 Inhibitor Trametinib in Combination with AKT Inhibitor GSK2141795 in Patients with Acute Myeloid Leukemia with RAS Mutations: A Phase II Study
B. Ragon, O. Odenike, M. Baer, W. Stock +10 more
2019Clinical Lymphoma, Myeloma & Leukemia59 citations Open access
Semantic Scholar
First-in-Class Selective HDAC6 Inhibitor (ACY-1215) Has a Highly Favorable Safety Profile in Patients with Relapsed and Refractory Lymphoma.
J. Amengual, J. Lue, Helen Ma, Renee Lichtenstein +4 more
2021The Oncologist52 citations Open access
Semantic Scholar
Inhibition of mTORC1/C2 signaling improves anti-leukemia efficacy of JAK/STAT blockade in CRLF2 rearranged and/or JAK driven Philadelphia chromosome–like acute B-cell lymphoblastic leukemia
Qi Zhang, Ce Shi, Li-Na Han, N. Jain +21 more
2018OncoTarget46 citations Open access
Semantic Scholar
T-cell lymphomas, a challenging disease: types, treatments, and future
Helen Ma, M. Abdul-Hay
2016International Journal of Clinical Oncology41 citations Open access
Semantic Scholar
Targeting CD123 in blastic plasmacytoid dendritic cell neoplasm using allogeneic anti-CD123 CAR T cells
Tian-Yu Cai, A. Gouble, K. Black, Anna Skwarska +29 more
2022Nature Communications39 citations Open access
Semantic Scholar
Outcomes in patients with aggressive B‐cell non‐Hodgkin lymphoma after intensive frontline treatment failure
E. Ayers, Shao-Ying Li, L. Medeiros, D. Bond +36 more
2020Cancer31 citations Open access
Semantic Scholar
Survival benefit in patients with peripheral T‐cell lymphomas after treatments with novel therapies and clinical trials
Helen Ma, B. Cheng, L. Falchi, E. Marchi +3 more
2019Hematological Oncology31 citations
Semantic Scholar
The Future of Combination Therapies for Peripheral T Cell Lymphoma (PTCL)
Helen Ma, Ardy Davarifar, J. Amengual
2018Current Hematologic Malignancy Reports28 citations
Semantic Scholar
The peripheral T-cell lymphomas: an unusual path to cure.
Helen Ma, E. Marchi, O. O'Connor
2020The Lancet Haematology21 citations
Semantic Scholar
HSP90 inhibitor AUY922 induces cell death by disruption of the Bcr-Abl, Jak2 and HSP90 signaling network complex in leukemia cells
Wen-Jing Tao, Sandip N. Chakraborty, Xiao-Hong Leng, Helen Ma +1 more
2015Genes & cancer20 citations Open access
Semantic Scholar
Ten-Day Decitabine with Venetoclax (DEC10-VEN) in Acute Myeloid Leukemia: Updated Results of a Phase II Trial
A. Maiti, C. Dinardo, C. Rausch, J. Cortes +45 more
2019Blood19 citations Open access
Semantic Scholar
Interim Analysis of Phase II Study of Venetoclax with 10-Day Decitabine (DEC10-VEN) in Acute Myeloid Leukemia and Myelodysplastic Syndrome
A. Maiti, C. Dinardo, J. Cortes, G. Borthakur +32 more
2018Blood19 citations Open access
Semantic Scholar
Potentially Inappropriate Medication Use in Elderly Non-Hodgkin’s Lymphoma Patients is Associated with Reduced Survival and Increased Toxicities
R. Lin, Helen Ma, R. Guo, A. Troxel +1 more
2017British Journal of Haematology19 citations Open access
Semantic Scholar
New directions in treating peripheral T-cell lymphomas (PTCL): leveraging epigenetic modifiers alone and in combination
Helen Ma, O. O'Connor, E. Marchi
2019Expert Review of Hematology18 citations
Semantic Scholar
Triple combination targeting methyltransferase, BCL-2, and PD-1 facilitates anti-leukemia responses in acute myeloid leukemia
Z. Zeng, A. Maiti, Shelley M. Herbrich, Tian-Yu Cai +8 more
2022Cancer13 citations
Semantic Scholar
Abstract 1004: GLS inhibitor CB-839 modulates cellular metabolism in AML and potently suppresses AML cell growth when combined with 5-azacitidine
Tian-Yu Cai, P. Lorenzi, D. Rakheja, Michael A. Pontikos +6 more
201612 citations
Semantic Scholar
Characterizing the Belinostat Response in Patients with Relapsed or Refractory Angioimmunoblastic T-Cell Lymphoma
A. Sawas, Helen Ma, A. Shustov, Pamela Hsu +4 more
2020Leukemia and Lymphoma10 citations Open access
Semantic Scholar
The Integration of PD1 blockade with epigenetic therapy is highly active and safe in heavily treated patients with T-cell lymphoma (PTCL) and cutaneous T-cell lymphoma (CTCL).
E. Marchi, Helen Ma, F. Montanari, A. Sawas +12 more
202010 citations
Semantic Scholar
c-Abl Activates Janus Kinase 2 in Normal Hematopoietic Cells*
Wen-Jing Tao, Xiao-Hong Leng, Sandip N. Chakraborty, Helen Ma +1 more
2014Journal of Biological Chemistry10 citations Open access
Semantic Scholar
Correction: Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia
Qi Zhang, B. Riley-Gillis, Li-Na Han, Yan-Nan Jia +37 more
2022Signal Transduction and Targeted Therapy8 citations Open access
Semantic Scholar
Combining Biology and Chemistry for a New Take on Chemotherapy: Antibody-Drug Conjugates in Hematologic Malignancies
Helen Ma, A. Sawas
2018Current Hematologic Malignancy Reports8 citations
Semantic Scholar
Novel Oxidative Phosphorylation Inhibitor IACS-010759 Induces AMPK-Dependent Apoptosis of AML Cells
Haeun Yang, Y. Tabe, K. Sekihara, Kaori Saito +12 more
20178 citations
Semantic Scholar
Mechanisms of Acquired Resistance to Venetoclax in Preclinical AML Models
Qi Zhang, Rongqing Pan, Li-Na Han, Ce Shi +8 more
20157 citations
Semantic Scholar
Belinostat Induces High Overall Response Rate (ORR) in Patients with Relapsed or Refractory Angioimmunoblastic T-Cell Lymphoma (AITL)
A. Sawas, Helen Ma, A. Shustov, Pamela Hsu +4 more
2019Blood6 citations Open access
Semantic Scholar
Outcomes in Molecular Subgroups and Resistance Patterns with Ten-Day Decitabine and Venetoclax (DEC10-VEN) in Acute Myeloid Leukemia
A. Maiti, C. Rausch, J. Cortes, N. Pemmaraju +46 more
2019Blood6 citations
Semantic Scholar
Upregulation of MAPK/MCL-1 Maintaining Mitochondrial Oxidative Phosphorylation Confers Acquired Resistance to BCL-2 Inhibitor Venetoclax in AML
Qi Zhang, Li-Na Han, Ce Shi, Rongqing Pan +13 more
20166 citations Open access
Semantic Scholar
Effective concentration of a multi-kinase inhibitor within bone marrow correlates with in vitro cell killing in therapy-resistant chronic myeloid leukemia
Chao-Feng Mu, Xiaoyan Wu, Helen Ma, Wen-Jing Tao +8 more
2016Molecular Cancer Therapeutics6 citations Open access
Semantic Scholar
Outcomes of Relapsed or Refractory Acute Myeloid Leukemia after Frontline Hypomethylating Agent with Venetoclax Regimens
A. Maiti, C. Rausch, J. Cortes, N. Pemmaraju +46 more
2019Blood5 citations
Semantic Scholar
Peripheral T-Cell Lymphoma Involvement of the Central Nervous System: Impact of Novel Therapeutics on Clinical Outcomes
J. Lue, Helen Ma, E. Marchi, John H. Spivack +1 more
2021Blood4 citations
Semantic Scholar
Management of Angioimmunoblastic T-Cell Lymphoma (AITL) and other T Follicular Helper Cell lymphomas (TFH PTCL).
Helen Ma, O. O'Connor, E. Marchi
2021Seminars in hematology (Print)4 citations
Semantic Scholar
Overcoming NOTCH1-Driven Chemoresistance in T-Cell Acute Lymphoblastic Leukemia Via Metabolic Intervention with Oxphos Inhibitor
Natalia Baran, A. Lodi, Yogesh Dhungana, Shannon R. Sweeney +46 more
20204 citations
Semantic Scholar
Low dose continuous lenalidomide in heavily pretreated patients with relapsed or refractory classical Hodgkin lymphoma: a retrospective case series
Helen Ma, B. Cheng, F. Montanari, J. Lue +4 more
2020Therapeutic Advances in Hematology4 citations Open access
Semantic Scholar
Oxphos Inhibition Induces Formation of Tunneling Nanotubes in AML Cells and Facilitates Mitochondrial Transfer from BM Stroma to AML That Contributes to Microenvironment-Mediated Drug-Resistance of AML
Haeun Yang, Y. Tabe, Kaori Saito, Kotoko Yamatani +16 more
2019Blood4 citations Open access
Semantic Scholar
Anti-Leukemia Combinatorial Efficacy of ABBV155, a B7H3-BCL-XL Inhibitor Antibody-Drug Conjugate, in Combination with Venetoclax through BCL-XL/BIM and BCL-2/BIM Complex Dissociations
Zhe Wang, Cassandra L. Ramage, Helen Ma, Hai-Chao Zhang +4 more
2024Blood3 citations
Semantic Scholar
Abstract CT160: The integration of PD1 blockade with epigenetic therapy is highly active and safe in heavily treated patients with T-cell lymphoma
E. Marchi, Helen Ma, F. Montanari, A. Sawas +19 more
2020Tumor Biology3 citations
Semantic Scholar
Generation of pralatrexate resistant T‐cell lymphoma lines reveals two patterns of acquired drug resistance that is overcome with epigenetic modifiers
L. Scotto, C. Kinahan, B. Casadei, M. Mangone +8 more
2020Genes, Chromosomes and Cancer3 citations Open access
Semantic Scholar
Polypharmacy and potentially inappropriate medication use in older patients with aggressive non-Hodgkin lymphoma (NHL) leads to inferior survival and increased treatment-related toxicities.
R. Lin, Helen Ma, R. Guo, M. Grossbard +2 more
20173 citations
Semantic Scholar
BCL-2 Antagonist ABT-199 Combined with Complex I Inhibitor IACS-010759 Blocks Mitochondrial Respiration and Facilitates Anti-Leukemia Efficacy in Pre-Clinical AML Models
Qi Zhang, Li-Na Han, Tian-Yu Cai, Vinitha M. Kuruvilla +9 more
20173 citations
Semantic Scholar
Combined Targeting of JAK2 with a Type II JAK2 Inhibitor and mTOR with a TOR Kinase Inhibitor Constitutes Synthetic Activity in JAK2-Driven Ph-like Acute Lymphoblastic Leukemia
Ce Shi, Li-Na Han, Qi Zhang, K. Roberts +16 more
20153 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Konopleva×26
Invite
M. Konopleva — researcher profile on SciRah
Qi Zhang×17
Invite
Qi Zhang — researcher profile on SciRah
M. Andreeff×17
Invite
M. Andreeff — researcher profile on SciRah
Li-Na Han×12
Invite
Li-Na Han — researcher profile on SciRah

×12

Invite

O. O'Connor — researcher profile on SciRah

Invite

E. Marchi — researcher profile on SciRah

Antonio Cavazos×10

Invite

Antonio Cavazos — researcher profile on SciRah

Invite

S. Konoplev — researcher profile on SciRah

Invite

C. Dinardo — researcher profile on SciRah

Invite

Tian-Yu Cai — researcher profile on SciRah

Invite

S. Kornblau — researcher profile on SciRah

Invite

V. Ruvolo — researcher profile on SciRah